AstraZeneca's MIND-BLOWING U.S. Investment Strategy You Won't Believe!

Mind-Blowing Pharma News: Fusion Pharmaceuticals Skyrockets 99.1%! 💊Подробнее

AstraZeneca sets ambition to deliver $80 billion annual by 2030Подробнее

The Ideal AstraZeneca CandidateПодробнее

AstraZeneca CFO on Earnings, US Inflation Reduction Act, China MarketПодробнее

AstraZeneca has productivity down to a scienceПодробнее

AstraZeneca vaccine found to be 79% effective in U.S. studyПодробнее

AstraZeneca CEO talks blowout earnings, global growth, new drugs, and pricingПодробнее

[Nov14@6:50PM] $AZN (AstraZeneca PLC American)Подробнее

Astrazeneca Aims to Almost Double Sales to $80 Billion by 2030Подробнее

More Time to Try New Things with the Power of ScienceПодробнее

AstraZeneca Warns UK on Innovation | FT BusinessПодробнее

Study: AstraZeneca Vaccine Reduces SpreadПодробнее

Streamlining Work at AstraZenecaПодробнее

How to prepare for uncertaintyПодробнее

Don't be this guy! Entitlement of the Seas! 🚢Подробнее

Why Startups Outshine Data Brokers for Big CompaniesПодробнее

seeing wife face for first time #shortsПодробнее

How AstraZeneca Simplified Employee Benefits with the help of TechnologyПодробнее

Not clear yet if we need a third booster for the vaccine: AstraZeneca CEOПодробнее

You Won't Believe This Tax on MillionairesПодробнее